PHR1377
Allopurinol
Pharmaceutical Secondary Standard; Certified Reference Material
Manufacturer: Supelco
CAS Number: 315-30-0
Synonym(S): Allopurinol, 1H-Pyrazolo(3,4-d)pyrimidin-4-ol, 4-Hydroxypyrazolo(3,4-d)pyrimidine, 4-Hydroxypyrazolo[3,4-d]pyrimidine, HPP
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | PHR1377-1-G | In Stock | ₹ 9,368.40 |
PHR1377 - 1 G
In Stock
Quantity
1
Base Price: ₹ 9,368.40
GST (18%): ₹ 1,686.312
Total Price: ₹ 11,054.712
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to BP 870traceable to Ph. Eur. A0350000traceable to USP 1013002
API family
allopurinol
CofA
current certificate can be downloaded
technique(s)
HPLC: suitablegas chromatography (GC): suitable
mp
>300 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
U.S. Pharmacopeia Allopurinol, 315-30-0, MFCD00599413, 250 mg | -- | ₹ 30,854.52 | ||
Sigma Aldrich Fine Chemicals Biosciences Allopurinol European Pharmacopoeia (EP) Reference Standard | 315-30-0 | MFCD00599413 | | -- | ₹ 17,007.90 | ||
Allopurinol Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 11,979.40 | ||
Sigma Aldrich Fine Chemicals Biosciences Allopurinol xanthine oxidase inhibitor | 315-30-0 | MFCD00599413 | 5G | -- | ₹ 9,027.27 | ||
Sigma Aldrich Fine Chemicals Biosciences Allopurinol xanthine oxidase inhibitor | 315-30-0 | MFCD00599413 | 25G | -- | ₹ 34,669.95 | ||
Sigma Aldrich Fine Chemicals Biosciences Allopurinol British Pharmacopoeia (BP) Reference Standard | 315-30-0 | MFCD00599413 | | -- | ₹ 28,455.97 | ||
eMolecules Ambeed / 1H-Pyrazolo[34-d]pyrimidin-4(5H)-one / 1g / 514323017 / A124580 / / 315-30-0 / MFCD00599413 / 136.114 / C5H4N4O | -- | ₹ 2,057.68 | ||
Allopurinol | -- | ₹ 41,791.50 | ||
Allopurinol | -- | ₹ 14,629.80 | ||
Allopurinol | -- | ₹ 1,869.00 - ₹ 11,125.00 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Allopurinol is a drug used in the treatment of chronic gout or hyperuricaemia. Its mode of action involves inhibition of xanthine oxidase, an important enzyme catalyzing the hydroxylation of hypoxanthine to xanthine and xanthine to uric acid.[1]
- Application: Allopurinol may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by spectrophotometry.[1][2]
- Biochem/physiol Actions: Inhibitor of xanthine oxidase and de novo pyrimidine biosynthesis. A classical agent in treatment of hyperuricemia and gout.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
- Footnote: To see an example of a Certificate of Analysis for this material enter LRAA1633 in the slot below. This is an example certificate only and may not be the lot that you receive.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral - Skin Sens. 1
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable